We Unite Evidence & Access to Improve Patient Outcomes
UBC is committed to helping ensure safe, affordable, and accessible treatments are available to patients under real-world conditions. This guiding principle informs everything we do and directly influences our customers’ products’ probability of long-term success and, ultimately, delivers better long-term patient outcomes.
Our Purpose
Better Patient Access and Outcomes Through Modernized Evidence Development
We are passionate about empowering patients and are deliberate in applying a patient-centric lens to all that we do. We leverage real-world data, generate evidence and insights, and deliver forward-thinking, evidence-based solutions to keep our customers and patients at the forefront of innovative approaches one patient at a time.
What We Do
Patients First. Powered By Evidence.
Leveraging our scientific and commercial leadership, data and analytics, and transformative technologies, we offer our customers flexible options to generate the relevant real-world data necessary to make more informed decisions earlier, address key stakeholder requirements, and facilitate access to therapy, ultimately delivering better long-term patient experiences and outcomes.
We are Dedicated to Driving Better Patient Access and Outcomes, by Embodying Five Core Values
We consider our customers to be valued partners, seeking to identify, design, and implement optimal pathways to help bring safe, affordable, and accessible treatments to the market.
Leading Evidence Development into the Future
UBC was founded in 2003 by industry experts with a passion for innovation and a commitment to help ensure safe, affordable, and accessible treatments for patients. We quickly honed our core strength – the generation, analysis, and communication of real-world evidence – with a patient–first approach, throughout the product lifecycle.
Over the last 20 years, we recognized the opportunity to build an organization tailored to meet the needs of all stakeholders – patients, prescribers, payers, and regulators – by providing evidence-development solutions to help biopharma mitigate risk, address product hurdles, and demonstrate safety, efficacy, and value under real-world conditions.
